InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,130.13
(
1.30%
)
US TECH 100
17,432.00
(
2.08%
)
Dow Jones
38,680.22
(
1.19%
)
Brent Oil
82.79
(
-1.01%
)
Bitcoin
61,877.30
(
4.66%
)
Post# of 251699
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: DFRAI post# 119935

Thursday, 05/12/2011 11:31:38 PM

Thursday, May 12, 2011 11:31:38 PM

Post# of 251699
It's not a amtter of right or wrong. It is a matter of what level of risk you think there is in a positive outcome. Objectively, the pivotal trial has higher risk than if the company ran a randomized Phase II trial first.

We don't recommend stocks. We provide research and leave it up to clients and their financial advisors to figure out what size position, if any, matches their risk profile and investment goals. If you want someone to tell you what to do there are lots of those services out there.

We've covered ONCy for a number of years and continue to do so.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up